TipRanks
PTC Therapeutics (CH:P91)
:P91

Compare PTC Therapeutics (P91) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
PTC Therapeutics
―
CHF4.42B
-129.04
8 Buy
1 Hold
1 Sell
Moderate Buy
Ionis Pharmaceuticals
$63.57
$7.31B
-12.76
-35.94%
17 Buy
4 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$1.83B
-12.15
-24.31%
3 Buy
9 Hold
4 Sell
Hold
Ultragenyx Pharmaceutical
$26.46
$1.43B
-2.55
-49.93%
10 Buy
10 Hold
0 Sell
Moderate Buy
Stoke Therapeutics
$33.09
$1.57B
-7.23
-11.06%
9 Buy
0 Hold
0 Sell
Strong Buy
Dyne Therapeutics
$26.34
$2.88B
-4.80
14.48%
13 Buy
0 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:P91
PTC Therapeutics
―
―
―
IONS
Ionis Pharmaceuticals
44.16
-25.80
-36.88%
SRPT
Sarepta Therapeutics
17.50
-5.88
-25.15%
RARE
Ultragenyx Pharmaceutical
14.89
-15.97
-51.75%
STOK
Stoke Therapeutics
24.29
-6.21
-20.36%
DYN
Dyne Therapeutics
15.97
1.41
9.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts